The aim of this study was to compare the effects of arm endurance training, arm strength training, a combination of arm endurance and strength training, and no arm training on endurance arm exercise capacity. A randomised controlled trial was undertaken with chronic obstructive pulmonary disease subjects randomised into one of four groups to complete 8 weeks of training: (a) arm endurance training (endurance group) consisting of supported and unsupported arm exercises, (b) arm strength training (strength group) using weight machines, (c) a combination of arm endurance and arm strength training (combined group), or (d) no arm training (control group). The primary outcome measurement was endurance arm exercise capacity measured by an endurance arm crank test. Secondary outcomes included functional arm exercise capacity measured by the incremental unsupported arm exercise test and health-related quality of life. A total of 52 subjects were recruited and 38 (73%) completed the study. When comparing the arm endurance group to the control group, there was a significant increase in endurance time of 6 min (95% CI 2-10, p < 0.01) following the interventions. When comparing the combined group to each of the control, endurance and strength groups, there was a significantly greater reduction in dyspnoea and rate of perceived exertion at the end of the functional arm exercise test for the combined group following the interventions. The mode of training to be favoured to increase endurance arm exercise capacity is arm endurance training. However, combined arm endurance and strength training may also be very useful to reduce the symptoms during everyday arm tasks.
Introduction
People with chronic obstructive pulmonary disease (COPD) experience difficulty with arm activities. [1] [2] [3] This difficulty is predominantly due to the alterations in the mechanics of breathing, such that the muscles required for arm activities are also required for breathing. 2 Consequently, when performing repetitive arm endurance tasks, people with COPD experience breathlessness and early cessation of these tasks 4 which may affect the quality of life (QoL). It is conceivable that arm exercise training could be a useful intervention to improve arm activities in people with COPD, however there is scant evidence in this area.
The most recent evidence-based guidelines for pulmonary rehabilitation recommend that unsupported arm exercise training be provided to people with COPD. 5 However, these guidelines also suggest that the best type of arm training is unknown. Three recent reviews have been published on arm exercise training in COPD. All the reviews suggested that the methodological quality of the randomised controlled trials (RCTs) was limited. The review that contained the lowest number of RCTs, four in total, suggested that results were so inconsistent that no recommendations could be made. 6 The other reviews that contained five RCTs 7 and six RCTs 8 suggested that there was evidence to support the use of arm exercise training to improve arm exercise capacity. Indeed, the one review which included a meta-analysis of data 8 concluded that unsupported arm exercise training increased arm endurance capacity, while arm strength training increased arm strength. It is clear that further RCTs are required to determine the optimal way to conduct arm exercise training in pulmonary rehabilitation particularly to evaluate the worth of combining arm endurance and strength training compared to these modes of training alone.
This study aimed to compare the effects of arm endurance training, arm strength training, a combination of arm endurance and strength training, and no arm training, on endurance arm exercise capacity. The hypothesis was that both arm endurance training and combined arm endurance and strength training would increase endurance arm exercise capacity compared to strength training alone or no training. A secondary aim was to compare the effects of arm endurance training, arm strength training, a combination of arm endurance and strength training, or no arm training on functional arm exercise capacity and health-related QoL.
Methods Subjects
Subjects were included if they had a medical diagnosis of COPD in global initiative for obstructive lung disease (GOLD) stage I to IV. 9 Subjects were excluded if they had a musculoskeletal, cardiovascular or neurological condition likely to adversely affect performance during assessment or training, if they had participated in supervised exercise training within the last 12 months, if they required oxygen supplementation, or if they were not able to understand instructions in English. Subjects were recruited from referrals to pulmonary rehabilitation at Royal Prince Alfred Hospital, Sydney, Australia.
Subjects received written and verbal information explaining the study and written consent was obtained prior to participation. Ethics approval was obtained from the Ethics Committee of Sydney South West Area Health Service (SSWAHS). The study was registered with the Australian Clinical Trials Registry ACTRN012605000679684.
Design
A prospective, single-blind RCT was undertaken with subjects randomised into one of four groups: arm endurance training (endurance group), arm strength training (strength group), arm endurance and strength training (combined group), and no arm training (control group).
Randomisation was via computerised random number generation, with the sequence concealed using opaque envelopes prepared by an investigator not involved in the study. An assessor, blinded to group allocation, performed the outcome measures at baseline and at the end of the intervention period.
Intervention
All groups had exercise training three times per week for 8 weeks and performed standard leg endurance and strength training during this period. Leg training involved endurance training for 20 min on a cycle beginning at 60% of peak watts estimated from the six-minute walk test (6MWT) 10 with the intensity progressed as able based on the symptoms of breathlessness and leg fatigue; and 20 min of walking at 80% of walking speed calculated from the 6MWT. Leg training also involved the strength training of the quadriceps and gluteal muscles, initially consisting of 2 sets of 10 repetitions at 60% of 1 repetition maximum (1 RM) progressing to 3 sets of 10 repetitions at 80% of 1 RM.
Arm endurance training. The endurance group and the combined group both performed endurance training which consisted of arm cranking and unsupported arm exercise. Arm cranking was performed for 15 min (continuous or intermittent) at 60% of the peak work rate achieved on the peak arm crank test. Intensity progression was made according to breathlessness and arm perceived exertion in order to maintain symptom scores at a moderate level of 3 on the 0-10 modified Borg category ratio scale. 11, 12 Unsupported arm exercise was performed for 5 min at one level below the maximal level achieved on the unsupported arm test (see outcome measures), with the level progressed according to breathlessness and arm perceived exertion in order to maintain symptom scores at a moderate level of 3 on the 0-10 modified Borg category ratio scale. 11, 12 Arm strength training. The strength group and the combined group performed the strength training. This training was aimed at the muscles that are involved both as accessory breathing muscles and as muscles that move the arm (i.e. pectoralis major and minor, serratus anterior, latissimus dorsi, trapezius, and biceps). These muscles were trained on three fixed weight machines (i.e. a pec deck, lat pull down, and bicep lifts) with resistance loading initially consisting of two sets (of 10 repetitions) at 60% of 1 RM. Training was progressed in subsequent sessions to three sets. The training work load was also progressed to 80% of 1 RM.
Measurements
Lung function. Spirometry and lung volumes were measured (Sensormedics Vmax 20 and Sensormedics V6200 Autobox Body Plethysmograph, respectively; Sensormedics Corporation, California) and compared to the predicted normal values of spirometry 13 and lung volumes. 14 Primary outcome. The primary outcome measurement, endurance arm exercise capacity, was measured by an endurance arm crank test. The work rate was set at 80% of the peak work rate determined from an incremental peak arm crank test. The endurance arm crank test was performed on an electrically braked bicycle ergometer (Seimens-Elma; Solina, Sweden) modified for arm work. Subjects exercised at 50-60 r/min. The work rate was maintained for the duration of the test and the test was stopped when subjects indicated that they could not continue or 20 min was reached. The identical work rate used at baseline was repeated for the follow-up testing. The time to completion of the endurance arm crank test was considered to represent endurance arm exercise capacity. A minimum difference of 1.75 min in endurance time between groups was taken to be clinically relevant based on this level of improvement being suggested as meaningful from leg cycle testing. 15 During the endurance arm crank tests, subjects breathed through a calibrated mass flow sensor with expired gas sampled on a breath-by-breath basis (Vmax 229 System; Sensormedics Corporation, California, USA) so that the oxygen consumption, carbon dioxide production (VCO 2 ), and minute ventilation could be determined. Heart rate and percentage oxygen saturation were obtained with a forehead probe attached to a pulse oximeter (Masimo Corporation, Irvine, USA). Subjects scored their dyspnoea and rate of perceived exertion (RPE) on a 0-10 modified Borg category ratio scale (0 ¼ nothing at all to 10 ¼ maximal). 11, 12 Outcomes for the endurance arm crank test were analysed both at the end of exercise and at isotime, defined as the end time of the shorter pre-or posttraining test.
Secondary outcomes. Functional arm exercise testing. Functional arm exercise capacity was measured by the duration of the dynamic incremental unsupported arm exercise test. 3, 16 This test initially involved the subjects lifting a 300-g bar in time with a metronome at a rate of 30 lifts/min. The height of the lifts was increased by 15 cm/min. Once the maximum vertical height was reached, the weight of the bar was increased each minute until the participants indicated that they could not continue. This test has been shown to be a reliable and valid measure of unsupported arm exercise capacity. 16 The same metabolic and cardiorespiratory variables were collected during this test as during the endurance arm crank test. Subjects scored their dyspnoea and RPE on a 0-10 modified Borg category ratio scale (0 ¼ nothing at all to 10 ¼ maximal). 11, 12 Health-related QoL. Subjects completed the St George's Respiratory Questionnaire (SGRQ), a valid and reliable measure of QoL in people with COPD. 17 
Statistical analysis
Statistical analyses were performed using SPSS Windows (version 17.0; SPSS, IBM, USA). Analyses of both the primary and secondary outcome measurements were conducted using intention to treat principles. Between-group comparisons of baseline data were made using one-way analysis of variance (ANOVA). Between-group comparisons of both the primary and secondary outcomes were made using analysis of covariance (ANCOVA) with study group as a factor and baseline value as the covariate. 18 Mean differences between groups and 95% confidence intervals are reported. All results were considered statistically significant where p < 0.05.
Results Subjects
A total of 52 subjects were recruited and 38 (73%) completed the study with 11 in the endurance group, 9 in the strength group, 9 in the combined group, and 9 in the control group (Figure 1) . No between-group differences were found in any baseline characteristic (Table 1) .
Compliance with trial method
The mean (SD) attendance of subjects in the training groups was not significantly different, being 16 (3) sessions in the endurance group, 19 (3) 
Primary outcomes
The mean end exercise and isotime values before and after the intervention for each group for the endurance arm crank test are presented in Table 2 . The difference in endurance time at end exercise in all the arm training intervention groups compared to the control group exceeded the minimum clinically important difference of 1.75 min (Table 3 ). However, the difference was only significantly greater when comparing the endurance group to the control group (p ¼ 0.01, Table 3 ). At isotime, there was a significantly greater reduction in VCO 2 when comparing the endurance group to both the control group (p ¼ 0.04) and the strength group (p ¼ 0.003).
Secondary outcomes
Functional arm exercise capacity. There was no significant difference in the change in time for the functional arm exercise test between groups following the interventions (Table 4 ). There was a significantly greater reduction in dyspnoea and RPE at the end of the functional arm exercise test when comparing the combined group with each of the control, endurance and strength groups (Tables 4 and 5) following the interventions.
Health-related QoL. The difference in the total score of the SGRQ between groups following the intervention was not statistically significant. However, when the combined group was compared to the control group and endurance group, the difference in the total score of the SGRQ following the intervention exceeded the minimum clinically important difference of 4 units (Table 6 ).
Discussion
This is the first study to examine the effect of different modes of arm exercise training in people with COPD on exercise and QoL outcomes. The results indicated a statistically significant increase in arm endurance time between the endurance group compared to the control group. In addition, all modes of arm exercise increased arm endurance capacity by a clinically relevant level compared to no arm training. Although no statistically significant differences in the improvement in arm endurance capacity were shown between the arm training groups, the magnitude of the improvement in the endurance group compared to the strength group and combined group was also greater than the clinically relevant level. To achieve improvements in arm endurance capacity the mode of training to be favoured is arm endurance training alone.
Endurance arm exercise capacity
The magnitude of improvement in endurance arm exercise capacity was greatest in the endurance group, being a mean (SE) of 6 (2) min greater than the control group. The increase in endurance time may be related to a reduction in arm fatigue as indicated by a lower RPE at isotime in the endurance group compared to the control group. The impressive increase in endurance arm exercise capacity following 8 weeks of endurance training highlights the importance of specificity of training principles, whereby people with COPD trained via endurance exercises will increase their endurance capacity. Interestingly, previous studies of supported and unsupported arm endurance training have failed to examine the effects on a measure of endurance capacity, instead examining the peak capacity. [19] [20] [21] A review which pooled the results of these studies concluded a very large positive effect of supported and unsupported arm endurance training on peak arm exercise capacity. 8 The present study now adds to this growing literature in highlighting that supported and unsupported arm endurance training significantly increases endurance arm exercise capacity compared to no training.
The magnitude of change in the strength group for arm endurance capacity was 2 (2) min greater than the control group following training despite no statistical difference between groups. Three RCTs have previously confirmed the positive effects of arm strength training on arm endurance capacity compared to no training or sham training. [22] [23] [24] However, this improvement was 4 (2) min less than that shown for the endurance group, suggesting that the arm strength training alone is not as beneficial at optimising endurance capacity as arm endurance training alone. These results agree with the studies examining leg endurance capacity where leg endurance training had greater benefits when compared to leg strength training. 25 In addition, the lower VCO 2 shown at isotime during the endurance arm crank test for the endurance group compared to the strength group suggests a greater physiological training effect for endurance training alone compared to strength training alone.
The magnitude of change in the combined group for arm endurance capacity was 3 (2) min greater than the control group following training despite no statistical difference between groups. This is the first study to indicate the positive effects of combining arm endurance and strength training compared to no arm training. However, the improvement in the combined group was 3 (2) min less than the endurance group, suggesting again that combining endurance and strength training is not as beneficial at optimising endurance capacity as endurance training alone. Interestingly, the one study that has examined leg endurance and strength training to leg endurance training alone on leg cycle endurance capacity showed the improvement in the combined training group to be 9.6 min less than the endurance training group. 26 Together these results suggest greater benefit on endurance capacity when training via endurance modalities alone.
Functional arm exercise capacity
It was the combined training group that showed significantly reduced dyspnoea and RPE at the end of the functional arm exercise test compared to all other groups. This result suggests that despite the combined training group not increasing functional capacity, they achieved a worthwhile result in experiencing a reduction in symptoms. As this test most closely reflects everyday tasks, this is an important finding suggesting the worth of combining both endurance and strength training.
Health-related QoL
None of the between-group differences for the QoL measure was statistically significant. This compares favourably to other studies which have examined the effects of unsupported arm training 4 and arm strength training 23 in addition to leg training and have also failed to show improvements in QoL over and above Week 0
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Week 8 Week 0
Week 8 the improvement from leg training alone, suggesting that leg training alone is sufficient to alter the QoL. However, the combined group did show a clinically important difference of 6 units and 5 units on the total score of the SGRQ compared to the control group and endurance group, respectively, following training, indicating a better QoL in the combined group. Perhaps, this improvement in QoL relates closely to the previous finding of reduced symptoms during the functional arm exercise test as this most closely reflects everyday tasks.
Study limitations
One of the limitations of this study was the small sample size per group. Consequently, all the nonsignificant results should be interpreted with caution as the power of the study is limited. In light of this, where possible, the clinical relevance of the size of the treatment effect for certain outcomes has been discussed.
Conclusion
This study examined different modes of arm exercise training in people with COPD. There was a significantly greater improvement in arm endurance time following arm endurance training compared to no arm training. Furthermore, the combined training group showed a significant improvement in symptoms at the end of the functional arm exercise test compared to all other groups. While the mode of training to be favoured to increase endurance arm exercise capacity is arm endurance training, combining arm endurance and strength training may also be useful to reduce symptoms during everyday arm tasks. Mean difference (95% CI) p value SGRQ, total À3 (À14, 8) À1 (À12, 9) À6 (À18, 5) 2 (À9, 12) À3 (À15, 8) À5 (À16, 6) 0.7 SGRQ, symptoms À7 (À23, 9) 2 (À13, 17) À9 (À25, 7) 9 (À6, 24) À2 (À18, 14) À11 (À26, 4) 0.4 SGRQ, activity À0.1 (À15, 15) 7 (À8, 21) 0.3 (À15, 16) 7 (À8, 21) 0.3 (À15, 16) À6 (À21, 8) 0.7 SGRQ, impact À3 (À16, 10) À4 (À17, 9) À10 (À23, 3) À1 (À14, 12) À7 (À20, 6) À6 (À19, 7) 0.5 ANCOVA: analysis of covariance; SGRQ: St George Respiratory Questionnaire.
